THE RIGHT TRIALS, PATIENTS, AND PLACES FOR MEANINGFUL ONCOLOGY RESEARCH
Innovative research requires an ingenious mediation of patient and program needs. Worldwide excels in the essentials while taking a vanguard approach to the latest in preclinical science and study design.
TEAM BACKGROUND MAKES A DIFFERENCE
Many of our oncology team members have spent time conducting research or clinical care themselves, giving them an edge in overcoming the operational and patient-centered challenges that often plague trials conducted in this space. From preclinical and dose escalation expertise to regulatory approval, we are just the right size to offer accessible, nimble attention and a bevy of the industry’s top talent. That’s why Worldwide is rated a top performer for staff, delivery, budget and loyalty across phase I-III CRO services by Industry Standard Research.
ALAEDDIN HOMSI, MS, BS
EXECUTIVE DIRECTOR, PROJECT MANAGEMENT, ONCOLOGY & HEMATOLOGY
He is a passionate and dedicated leader in the oncology clinical research space with 20 years supporting biotech companies in their development of oncology treatments from proof-of-concept to commercialization. During his tenure at Worldwide, he has built a track record of delivering oncology study requirements on time or ahead of schedule. Alaeddin blends operational expertise and passion for patients. His robust oncology portfolio includes research work with metastatic breast cancer, prostate cancer, GIST, glioblastoma, early-phase solid tumors, and more. His passion for oncology extends back to his undergraduate studies, working with p53 and apoptosis of breast cancer cells in athymic mice, and it has grown into a lifelong career in cell and cancer biology. Alaeddin serves on Worldwide’s oncology leadership team.
SENIOR ONCOLOGY PROJECT MANAGER
Jana has more than a decade of experience in oncology therapeutic development, providing clinical trial management expertise with a strong grounding in regulatory affairs. With a background in CROs, sponsor companies, and academia, her knowledge spans the entire breadth of the clinical development space. Her personal dedication to therapeutic advancement in the service of cancer patients drives her commitment to supporting sponsors in their development goals.
DIRECTOR, PROJECT MANAGEMENT, ONCOLOGY AND RARE DISEASES
Leanne has more than 25 years of project management experience in CROs and the pharmaceutical industry, specializing in oncology studies. She is skilled in providing support and oversight to Worldwide’s large national and global project and program management teams. She mentors staff and assesses program metrics to ensure quality, time, and budget deliverables are met. She has supported all research stages, including CMC, pharmacology, toxicology, regulatory, and clinical studies phase I-IV, and has worked on more than 10 multi-indication development programs. Her therapeutic experience in oncology includes solid tumors, ovarian cancer, hematological malignancies, acute myeloid leukemia (requiring stem cell transplant, peripheral, and cord blood), breast cancer, and glioblastoma.
DEDICATED TO DELIVERING UNCOMMON EXPERTISE AND PARTNERSHIPS
Can your current CRO offer a team like ours? We don’t think so. Here’s why.Learn More
The Modern Oncology Research Landscape: Staying Ahead of the Game
We’ve got a few good insights into the changing world of oncology research. Want to take a peek?Learn More
Optimizing Site and Patient Engagement in Rescue Studies
Learn how to keep an oncology study on track with these solutionsLearn More
Worldwide works with sponsors, leading subject matter experts, patients, and an experienced internal, executive-level team to give each and every oncology trial the right foundation for success and good decisions—no matter their stage of development.
Worldwide has a growing track record of successfully shepherding compounds from early-phase conceptualization through commercialization. And for those in need of study rescue, leading-edge study design consultation, or a fresh approach? We do that, too.
Taking a unique approach to site feasibility and selection, Worldwide’s dedicated team of medical monitors and global project leads are directly involved in communication and relationship-building with sites. This results in rock-solid services and an irreplaceable “in-the-trenches” understanding of therapies, the competitive landscape, and the patient journey.
Worldwide makes patient-centered logistics a key focus of all oncology trials, finding the right patients by partnering with indication-specific recruitment experts and successfully equipping research centers to reach patients beyond academic hubs.
Expertise You Can Rely On
We’ve cultivated a tenured, talented team of experts to craft unique, resourceful solutions for each and every project. Forge a partnership that matters and let Worldwide Clinical Trials Oncology introduce you to the research experience you deserve.
- Acute Myelocytic Leukemia (AML)
- Advanced Solid Tumors
- Breast Cancer
- Cervical Cancer
- Chemo induced anorexia or cachexia
- Colorectal Cancer
- Endometrial Cancer
- Gastrointestinal Stromal Tumor (GIST)
- Glioblastoma Multiforme (GBM)
- Hepatocellular Carcinoma
- Idiopathic Thrombocytopenia Purpura
- Myelodysplastic Syndrome
- Non-Hodgkins Lymphoma
- Non-Small Cell Lung Cancer
- Ovarian Cancer
- Pancreatic Cancer
- Post-Essential Thrombocythemia Myelofibrosis (Post-ET MF)
- Prostate Cancer
- Renal Cell Carcinoma
- Stomach Cancer
- Tenosynovial Giant Cell Tumor
Our Dedicated Team
Global Head of Regulatory Strategy
Senior Medical Director, Medical Affairs, Oncology
Senior Medical Director, Medical Affairs
Senior Vice President, Project Management
Vice President, Oncology Scientific Solutions
Executive Director, Project Management, Oncology & Hematology
Senior Director, Project Management
Executive Medical Director, Therapeutic Area Medical Lead, Medical Affairs